RXRX- Recursion Pharmaceuticals, Inc.

Name: Recursion Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Recursion Pharmaceuticals, Inc. (RXRX) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 22 sells. RXRX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Dir	Borgeson Blake	6.65M	$21.48M	-
Dir	Gibson Christopher	4.52M	$14.61M	-
CEO	Khan Najat	2.26M	$7.31M	-
Dir	Li Dean Y	1.24M	$4.01M	-
Other	Hallett David	1.11M	$3.58M	-

Activity

Buys and sells only

Transactions

10 filings · page 21

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 21, 2021	Borgeson Blake69	Director	Sell	9,625	$18.75	$180,478.38	-0.1%	-65.0%	-59.1%
Dec 16, 2021	Larson Tina Marriott73	President And COO	Sell	2,500	$18.74	$46,848.40	-1.7%	-62.9%	-52.4%
Dec 16, 2021	Gibson Christopher70	Chief Executive Officer	Sell	200	$20.01	$4,001.00	-0.8%	-62.9%	-52.4%
Dec 13, 2021	Gibson Christopher70	Chief Executive Officer	Sell	100	$20.02	$2,001.50	-0.4%	-68.3%	-54.5%
Dec 9, 2021	Gibson Christopher70	Chief Executive Officer	Sale+OE	11,750	$20.13	$236,562.17	-14.3%	-59.1%	-54.2%
Dec 7, 2021	Borgeson Blake69	Director	Sell	9,625	$20.32	$195,533.45	-	-65.8%	-55.0%
Dec 7, 2021	Gibson Christopher70	Chief Executive Officer	Sell	19,792	$20.48	$405,432.76	-0.1%	-65.8%	-55.0%
Dec 7, 2021	Li Dean Y73	Director	Sell	15,900	$20.48	$325,630.39	-0.6%	-65.8%	-55.0%
Nov 19, 2021	Li Dean Y73	Director	Sell	19,100	$20.16	$384,962.04	-1.6%	-46.3%	-50.4%
Nov 18, 2021	Larson Tina Marriott73	President And COO	Sell	2,500	$18.92	$47,307.92	-2.4%	-39.6%	-48.9%

← PrevPage 21Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC